8/19/18
The ACIP’s current summary of vaccination recommendations for the 2018-2019 influenza season are now available. More detailed information on influenza immunization recommendations from the ACIP may be found in the August 24th issue of the MMWR. Fortunately, several vaccine options are accessible to physicians. This information is an extremely helpful resource as immunization season has begun and there is a plethora of acronyms and vaccine choices to be familiar with. There has also been considerable discussion surrounding the use of High Dose Influenza vaccine FluzoneHD®(HD-IIV3) for older adults and this issue of the MMWR reports the “evidence has accumulated for its superior efficacy and effectiveness compared to SD-IIV3 in this population…”. Additional useful information regarding influenza season, Flu vaccine coding and billing information has been provided by Sanofi Pasteur in a separate site.